Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Adverse trends in male reproductive health and decreasing fertility rates

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Postoperative mobilisation as an indicator for the quality of surgical nursing care

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Ovarian cancer (OC) is the second most frequent type of gynecological cancers worldwide. In the past decades, the development of novel diagnostic and prognostic biomarkers available for OC has been limited, reflecting by the lack of specificity of such markers or very costly management. Microarray expression profiling has shown very effective results in exploring new molecular markers for patients with OC. Nonetheless, most screenings are focused on mutations or expression of molecules that are translated into proteins, corresponding to only 2% of the total human genome. In order to account for the vast majority of transcripts, in the present exploratory study, we assessed the expression levels of a comprehensive panel of noncoding RNA in different subtypes of OC. We further evaluated their association with patient overall survival (OS) and aggressive forms of the disease, such as tumor type, stage, and chemotherapy resistance. By microarray profiling in a total of 197 epithelial OC patients (162 serous carcinomas, 15 endometrioid carcinomas, 11 mucinous carcinomas, and 9 clear cell carcinomas), we found two candidates, SNORA68 and SNORD74, which associated with OS and poor clinicopathological features. The overexpression of those two targets combined was correlated with shorter OS and progression-free survival. That association was further observed to correlate with a more aggressive form of the disease. Overall, the results indicate that a panel comprised of SNORA68 and SNORD74 may be clinically relevant, where patients could be offered a more individualized, targeted follow-up, given its further validation on future prospective clinical studies.

Original languageEnglish
JournalAnimal Reproduction Science
Issue number3
Pages (from-to)757-765
Number of pages9
Publication statusPublished - Mar 2021

    Research areas

  • ncRNA profiling, Biomarker, Ovarian cancer, High throughput

ID: 61424023